How the Framingham Heart Study Has Revolutionized Healthcare — 10 Groundbreaking Moments
The Framingham Heart Study, led by Boston University, has been reshaping how the world understands heart disease, brain aging, and human health for over 78 years — and a major new feature in BU’s The Brink highlights just how profound that impact has been.
The article spotlights 10 of the study’s most groundbreaking contributions to medicine, drawn from a deep dive in the Journal of the American College of Cardiology. At the center of it all: the discovery that cholesterol, blood pressure, diabetes, smoking, diet, and sedentary lifestyle are the core risk factors for cardiovascular disease — insights that have saved millions of lives around the world.
A Study That Keeps Evolving
Now spanning more than 15,000 participants across three generations, the Framingham Heart Study continues to break new ground. In January 2025, Dr. Donald Lloyd-Jones — a past president of the American Heart Association and chief of preventive medicine at BU’s Chobanian & Avedisian School of Medicine — became the study’s sixth principal investigator.
AI Meets Brain Aging
One of the study’s most exciting recent frontiers is the intersection of artificial intelligence and cognitive health. Dr. Rhoda Au, Professor of Anatomy and Neurobiology at BU, has been collecting and analyzing digital voice recordings of older Framingham participants — uncovering subtle speech patterns that may signal cognitive impairments likely to progress to dementia. In collaboration with researchers at the BU Rafik B. Hariri Institute for Computing and Computational Science & Engineering, Dr. Au helped develop an AI program with the potential to predict a patient’s likelihood of developing Alzheimer’s disease years before symptoms appear.
Read the Full Story: 10 Ways the Framingham Heart Study Has Revolutionized Healthcare – BU The Brink